1. Tsiodras S, Kelesidis I, Kelesidis T, Stamboulis E, Giamarellou H. Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect. 2005; 51:343–54.
Article
2. Ovetchkine P, Brugieres P, Seradj A, Reinert P, Cohen R. An 8-old boy with acute stroke and radiological signs of cerebral vasculitis after recent Mycoplasma pneumoniae infection. Scand J Infect Dis. 2002; 34:307–9.
3. Ryu JS, Kim HJ, Sung IY, Ko TS. Posterior cerebral artery occlusion after Mycoplasma pneumoniae infection associated with genetic defect of MTHFR C677T. J Child Neurol. 2009; 24:891–4.
4. Leonardi S, Pavone P, Rotolo N, La Rosa M. Stroke in two children with Mycoplasma pneumoniae infection. A causal or casual relationship? Pediatr Infect Dis J. 2005; 24:843–5.
5. Lee CY, Huang YY, Huang FL, Liu FC, Chen PY. Mycoplasma pneumoniae-associated cerebral infarction in a child. J Trop Pediatr. 2009; 55:272–5.
Article
6. Fu M, Wong KS, Lam WW, Wong GW. Middle cerebral artery occlusion after recent Mycoplasma pneumoniae infection. J Neurol Sci. 1998; 157:113–5.
Article
7. Tanir G, Aydemir C, Yilmaz D, Tuygun N. Internal carotid artery occlusion associated with Mycoplasma pneumoniae infection in a child. Turk J Pediatr. 2006; 48:166–71.
8. Parker P, Puck J, Fernandez F. Cerebral infarction associated with Mycoplasma pneumoniae. Pediatrics. 1981; 67:373–5.
Article
9. Visudhiphan P, Chiemchanya S, Sirinavin S. Internal carotid artery occlusion associated with Mycoplasma pneumoniae infection. Pediatr Neurol. 1992; 8:237–9.
Article
10. Antachopoulos C, Liakopoulou T, Palamidou F, Papathanassiou D, Youroukos S. Posterior cerebral artery occlusion associated with Mycoplasma pneumoniae infection. J Child Neurol. 2002; 17:55–7.
Article
11. Kim GH, Seo WH, Je BK, Eun SH. Mycoplasma pneumoniae associated stroke in a 3-year-old girl. Korean J Pediatr. 2013; 56:411–5.
12. Papaevangelou V, Falaina V, Syriopoulou V, Theodordou M. Bell’s palsy associated with Mycoplasma pneumoniae infection. Pediatr Infect Dis J. 1999; 18:1024–26.
Article
13. Kim EK, Youn YS, Rhim JW, Shin MS, Kang JH, Lee KY. Epidemiological comparison of three Mycoplasma pneumoniae pneumonia epidemics in a single hospital over 10 years. Korean J pediatr. 2015; 58:172–7.
14. Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R, Matsubara K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob Agents Chemother. 2008; 52:348–50.
15. Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2006; 50:709–12.
16. Yang J, Hooper WC, Phillips DJ, Talkington DF. Cytokines in Mycoplasma pneumonia infection. Cytokine Growth Factor Rev. 2004; 15:157–68.
17. Miyashita N, Akaike H, Teranishi H, Ouchi K, Okimoto N. Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy. Antimicrob Agents Chemother. 2013; 57:5181–5.
Article
18. Macovei L, Gurzu A, Alexandrescu DM, Georgescu CA. Simultaneous tromboembolic events in a patient with heterozygous MTHFR mutation. Int Arch Med. 2015; 8.
Article
19. Alba MA, Espígol-Frigolé G, Prieto-González S, Tavera-Bahillo I, García-Martínez A, Butjosa M, et al. Central nervous system vasculitis: still more questions than answers. Curr Neuropharmacol. 2011; 9:437–48.
20. Lukán N. Intravenous immunoglobulin therapy in
primary vasculitides. In : Amezcua-Guerra LM, editor. Advances in the diagnosis and treatment of vasculitis. 4th ed. Rijeka: InTech;2011. p. 149–66.